142 related articles for article (PubMed ID: 38910799)
1. The effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: a systematic review and meta-analysis of randomized controlled trials.
Soliman Y; Nazir A; Abuelazm M; Seri A; Mahmoud A; Abdelazeem B
Proc (Bayl Univ Med Cent); 2024; 37(4):700-704. PubMed ID: 38910799
[TBL] [Abstract][Full Text] [Related]
2. Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: a meta-analysis of randomized trials.
Hu J; Zhou Y
Blood Press; 2023 Dec; 32(1):2242501. PubMed ID: 37652401
[TBL] [Abstract][Full Text] [Related]
3. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for hypertension-induced left ventricular hypertrophy.
Leache L; Gutiérrez-Valencia M; Finizola RM; Infante E; Finizola B; Pardo Pardo J; Flores Y; Granero R; Arai KJ
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012039. PubMed ID: 34628642
[TBL] [Abstract][Full Text] [Related]
5. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.
Soliman EZ; Byington RP; Bigger JT; Evans G; Okin PM; Goff DC; Chen H
Hypertension; 2015 Dec; 66(6):1123-9. PubMed ID: 26459421
[TBL] [Abstract][Full Text] [Related]
6. Intensive Blood Pressure Lowering Improves Left Ventricular Hypertrophy in Older Patients with Hypertension: The STEP Trial.
Deng Y; Liu W; Yang X; Guo Z; Zhang J; Huang R; Yang X; Yu C; Yu J; Cai J;
Hypertension; 2023 Sep; 80(9):1834-1842. PubMed ID: 37259845
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study.
Johnson K; Oparil S; Davis BR; Tereshchenko LG
J Am Heart Assoc; 2019 Apr; 8(8):e011961. PubMed ID: 30943832
[TBL] [Abstract][Full Text] [Related]
10. Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.
Ascher SB; de Lemos JA; Lee M; Wu E; Soliman EZ; Neeland IJ; Kitzman DW; Ballantyne CM; Nambi V; Killeen AA; Ix JH; Shlipak MG; Berry JD
J Am Coll Cardiol; 2022 Oct; 80(16):1516-1525. PubMed ID: 36229087
[TBL] [Abstract][Full Text] [Related]
11. Diastolic blood pressure reduction contributes more to the regression of left ventricular hypertrophy: a meta-analysis of randomized controlled trials.
Zhang K; Chen J; Liu Y; Wang T; Wang L; Wang J; Huang H
J Hum Hypertens; 2013 Nov; 27(11):698-706. PubMed ID: 23535988
[TBL] [Abstract][Full Text] [Related]
12. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
13. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A
Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744
[TBL] [Abstract][Full Text] [Related]
14. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
Okin PM; Wachtell K; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Julius S; Lindholm LH; Nieminen MS; Edelman JM; Hille DA; Dahlöf B
JAMA; 2006 Sep; 296(10):1242-8. PubMed ID: 16968848
[TBL] [Abstract][Full Text] [Related]
15. Features of left ventricular hypertrophy in patients with metabolic syndrome with or without comparable blood pressure: a meta-analysis.
Li NY; Yu J; Zhang XW; Wang SX; Chang P; Ding Q; Ma RX; Chen QF; Zhao F; Bai F
Endocrine; 2013 Jun; 43(3):548-63. PubMed ID: 23371816
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias.
Chatterjee S; Bavishi C; Sardar P; Agarwal V; Krishnamoorthy P; Grodzicki T; Messerli FH
Am J Cardiol; 2014 Oct; 114(7):1049-52. PubMed ID: 25118122
[TBL] [Abstract][Full Text] [Related]
17. Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis.
Pierdomenico SD; Cuccurullo F
Am J Hypertens; 2010 Aug; 23(8):876-81. PubMed ID: 20414193
[TBL] [Abstract][Full Text] [Related]
18. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
Bang CN; Devereux RB; Okin PM
J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
[TBL] [Abstract][Full Text] [Related]
19. Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: A meta-analysis.
Wang J; Chen Y; Xu W; Lu N; Cao J; Yu S
PLoS One; 2019; 14(4):e0215362. PubMed ID: 30978254
[TBL] [Abstract][Full Text] [Related]
20. Is Left Ventricular Hypertrophy a Valid Therapeutic Target?
Brooks JE; Soliman EZ; Upadhya B
Curr Hypertens Rep; 2019 May; 21(6):47. PubMed ID: 31111289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
